Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)

SHA:600165 Revenue

Ningxia Zhongke Biotechnology had revenue of 136.44M CNY in the quarter ending September 30, 2026, with 22.08% growth. This brings the company's total for the last twelve months to 527.94M, up 8.15% year-over-year. In the year 2025, Ningxia Zhongke Biotechnology had annual revenue of 444.48M with 28.72% growth. That makes Ningxia Zhongke Biotechnology the 24,503rd largest company in the world by revenue and 4,392nd in China.

• Revenue (ttm): 527.94M
• Revenue Growth: +8.15%
• P/S Ratio: 8.54
• Revenue / Employee: 584.01K
• Employees: 904
• Market Cap: 4.56B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Lauric Acid 260.08M 58.5%
• Activated Carbon Business 184.48M 41.5%

By Geography

Chart

• China 403.58M 90.8%
• Foreign 40.90M 9.2%

Fiscal year ended Dec 31, 2025 See the full SHA:600165 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	444.48M	99.16M	28.72%
Dec 31, 2024	345.32M	59.63M	20.87%
Dec 31, 2023	285.69M	-395.44M	-58.06%
Dec 31, 2022	681.13M	432.42M	173.86%
Dec 31, 2021	248.72M	129.60M	108.80%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error